GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Price-to-Funds-From-Operations

AP Biosciences (ROCO:6945) Price-to-Funds-From-Operations : (As of Dec. 14, 2024)


View and export this data going back to 2023. Start your Free Trial

What is AP Biosciences Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


AP Biosciences Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 17th Floor, Taipei, TWN
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.